☆ 4.5 Article

Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

Soheil Hassanipour et al.

Summary: The meta-analysis of Favipiravir in the treatment of COVID-19 showed significant clinical improvement in the Favipiravir group compared to the control group after seven days of hospitalization. However, there was no significant difference in viral clearance and oxygen therapy requirement between the two groups. The mortality rate was approximately 30% lower in the Favipiravir group, but this finding was not statistically significant.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Dermatology

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

C. Galvan Casas et al.

BRITISH JOURNAL OF DERMATOLOGY (2020)

添加到收藏夹

Review Dermatology

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist

Antonio Martinez-Lopez et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

添加到收藏夹

Article Dermatology

The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Esther E. Freeman et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Diagnosing and managing drug allergy

Elissa M. Abrams et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)

添加到收藏夹

Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19

相关参考文献

The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist

The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Diagnosing and managing drug allergy

导出引文

分享论文